chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3pm patient woke up due to lower back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (3pm patient woke up due to lower back pain) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     Concomitant products included IBUPROFEN for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced BACK PAIN (3pm patient woke up due to lower back pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BACK PAIN (3pm patient woke up due to lower back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included Heating pad since 26Jan2021; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
A week after second dose, I experienced profound hearing loss in my right ear. i also experienced severe equilibrium issues with my balance to which I still experience today.
Patient did not disclose previous vaccinations with of the following: 5/5/21 Covid19 Lot #023C21A at Pharmacy 6/2/21 Covid19 Lot #033C21A at Pharmacy   Patient completed Pfizer series at Health Center 10/4/21 Lot #30130BA IM right arm. After this, it was discovered that the patient had completed presumably a Moderna series in June. Attempts to reach the patient have been unsuccessful.
sore arm, brain fog, headache, swollen lymph nodes, pain in brain stem, sore neck, lethargy, diarrhea, bowel discomfort, arthritis flare-up
On 5/3/99, the pt received her 1st dose of Lymerix with no untoward effects. On 6/3/99, she received the 2nd dose and became pregnant. The pt's LMP was 6/1/99 and her estimated date of delivery is 3/1/00. The pt's physician stated the pt has not been seen since 8/13/99. The most recent information received on 4/25/00 does not provide an outcome.
Pt to ED 8/18 for intermittent periods of becoming unresponsive.  Pt having seizure like activity. 8/20 No seizure like activity, patient denies any chest pain/SOB, denies pain. Stated that lately she has become "more forgetful". Patient is A&O x 4, no S/S of acute distress noted. 8/21 no seizure like activity, VSS and no S/S of acute distress. 8/22 pt COVID+, not a candidate for antiviral therapy. 8/24 pt with sore throat. Pt discharged 8/25.
Day one after dose Lt axilla pain. Day two after dose started with vision changes (diplopia), possibly ocular nerve palsy.  Day three after dose left eye drifting to towards my nose and vision worsened.  Day four after dose vision worsened. Day five after dose slight vision correction.  Day six after dose some improvement, but not totally resolved.
LOCALIZED REACTION ON RIGHT THIGH 7X7 CM LARGER ON DAY 2 THAN DAY ONE POST INJECTION TREATED WITH ZYRTEC 10 MG PO DAILY FOR A WEEK
upon discovery from the administrator of the shot, and errant dose of Pfizer-BioNTech COVID-19  instead of the Bivalent Pfizer Booster
Left periorbital eye pain and facial nerve pain also on the left side - the patient does not have inflammation of the eye - gave VALTREX 1g tid for 10 days.
Narrative:  Per note on 9/22/21, patient cancelled second dose after experiencing significant side effects with the first dose that included "headache, fevers, and soreness" and the myalgias had persisted since then. The symptoms were not well controlled on celecoxib and methocarbamol. Patient was diagnosed with RA sometime in early 2022. Of note, patient had sedimentation rate of 44, CRP of 2.885, and a positive ANA in October of 2021. Per note on 6/15/22, the COVID vaccine "triggered RA per rheumatology".
Big round red spot at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Big round red spot at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Big round red spot at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Big round red spot at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was unknown. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-018078 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-018078:
Pt. received Anthrax Vaccine 5 days prior than the due date. NO side effects or adverse reactions.
The next day after vaccine began to experience headaches, a dropping heart rate declining over the next week into the 40's.  Extreme chest pain, heaviness, tightening and crushing on the left side and heart.  EKG diagnosed onset of bradycardia and T-Wave Abnormality.
VACCINE ADMINISTERED TO PATIENT AFTER 2 HOUR ROOM TEMP EXPIRATION.  PATIENT 14 WEEKS PREGNANT AT TIME OF VACCINE ADMINISTRATION.
Pain in arm radiating to elbow not alleviated upon seeing physician on 12-21-18. Pain is aggravated by lifting and movement. On NSAIDS for 2 weeks and if no improvement considering steroid injection, orthopaedic review or physical therapy.
Pt states that beginning approximately one week after her vaccine, she experiences low grade fevers of 99-100 degress F every 5 to 7 days. By the 4th week after vaccination, they had increased in frequency to every 3 to 5 days. She had no other adverse reactions. She treated sometimes with ibuprofen. She also states she had COVID in early 12/2020.
Swelling and pressure behind right ear spreading to neck and jaw; Swelling and pressure behind right ear spreading to neck and jaw; Swelling and pressure behind right ear spreading to neck and jaw; Swelling and pressure behind right ear spreading to neck and jaw; Swelling and pressure behind right ear spreading to neck and jaw; partial hearing loss; Stiff jaw; swollen lymph nodes on side of injection; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA6780) via an unspecified route of administration in the right arm on 03Aug2021 at 09:15 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and erythromycin (MANUFACTURER UNKNOWN); both on unknown date for unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Aug2021 at 14:00, the patient experienced swelling and pressure behind right ear spreading to neck and jaw, partial hearing loss, stiff jaw and swollen lymph nodes on side of injection. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling and pressure behind right ear spreading to neck and jaw, partial hearing loss, stiff jaw and swollen lymph nodes on side of injection was not recovered at the time of this report.
swollen lymph nodes in the left clavicle, in the left armpit and behind the neck in the lower left; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 17 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Jun2021 15:15 (Lot number: EW0167) at the age of 17 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 10Jun2021, outcome "recovering", described as "swollen lymph nodes in the left clavicle, in the left armpit and behind the neck in the lower left". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of lymphadenopathy.  Additional information: The patient had no known allergies and other medical history. The patient did not had covid prior vaccination. The patient was tested for covid post vaccination.   No follow-up attempts are possible. No further information is expected.
Extreme full body pain, intense headache, chest pains, Sleeplessness, shortness of breath lasting about 3 days. Lingering fatigue a week later.
Swelling, soreness in upper arm. Next morning sharp pain from palm of hand up arm. Very painful, unable to use muscle on arm. Upper arm swelling goes away. Pain from palm to elbow continues and is now a bit swollen and bruise approx 2" x 4" is evident.
I waited to be monitored for 15 mins and left immediately after. On my car ride away I started noticing small bumps and a red rash on my chest and neck that looked like hives.   My throat felt very, very sore and turned bright red. It was difficult to swallow.
Patient is 10 years old, was given Pfizer COVID vaccine for ages 12 and up. No adverse effects reported.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies provided. On 30-JAN-2017, the patient was vaccinated with improperly stored dose of M-M-R II  lot # L049314 with expiration date 03-DEC-2017; site, dose and route of administration were not reported). The reason of the call was temperature alarm received via Digital Data Logger. It was reported that the vaccine was exposed to temperature of -14.4 Celsius degrees for 54 minutes before administration to the patient. No previous temperature excursion was reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected, all information has already been obtained. Sender's Comments: US-009507513-1611USA011831: US-009507513-1611USA004113: US-009507513-1705USA009742:
pt 24 hrs p/vax on back unresponsive & cyanotic not breathing-stimulated by mom & taken to ER;
When I walk I kind of have a little short of breathe; Short breathing when I walk; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date Aug2021 (Lot number: FC3181) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Neuralgia" (unspecified if ongoing), notes: Verbatim: Nerve pain. Concomitant medication(s) included: GABAPENTIN taken for neuralgia. The following information was reported: DYSPNOEA (non-serious) with onset 19Aug2021, outcome "not recovered", described as "When I walk I kind of have a little short of breathe; Short breathing when I walk". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient had not received any vaccination 4 weeks prior to COVID 19 Vaccine.  No follow-up attempts are possible. No further information is expected.
Pt vaccinated with Series (3 doses) of Engerix-B reported to have fever and inflammed liver.  Reporting nusre does "Does not think that this hepatitis is due to Engerix-B.
headache for 7 days; This consumer reported for a 35-year-old male patient (husband) that: A 35-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot number and Expiry date was not reported), dose 1 via an unspecified route of administration on an unspecified date (age at vaccination was 35-year-old) as dose 1, single dose for covid-19 immunisation. The patient medical history was not reported. The patient concomitant medications were not reported. Caller states her husband received the Pfizer Covid vaccine. On an unspecified date, the caller's husband had a headache for 7 days since 1st vaccine dose. He states that headache goes away with a pill and then comes back. The headache pain is 5/10. Asking, when should he go to the emergency room and how long will the headache last. Caller calling on behalf of her husband who reported headaches after the first dose of Pfizer Covid 19 vaccine. Stated that she wanted to know if this is something to be expected after first dose. Agent stated that she was provided with Medical Information department phone number. Clarified that she wanted to know is it regular to have a headache after the first one or does she have to go emergency room. The patient underwent lab tests and procedures which included pain assessment: 5/10, headache pain is 5/10 on an unspecified date. Treatment received for the event. Outcome of the event was not recovered.   Information on lot/batch number has been requested.
On the night of Dec. 1st, I went to bed with extremely itchy palms of my hands and feet; I had never experienced a burning itch like this before. On Dec. 2, I awoke with hives on my lower back and abdomen and went to urgent care. I was given a steroid injection and a course of prednisone. The urgent care doctor suspected a contact allergy or Rash. The following day, my ears were flushed, I had small hives around my eyes, and hives on the base of my neck. I called my primary care physician but was seen by a PA who could not make a diagnosis but suspected an allergic reaction to ?something.? Over the past 17 days, I have noticed that the hives are induced by the slightest scratch against my skin (dermatographia). Claritin seems to alleviate the itching and burning ears slightly. I have not changed my diet, detergent, no new animals, no new foods, etc. I have never had a reaction like this before. The itching and burning is extreme. I have found a few internet posts of delayed uticaria with covid vaccination. Thus, since I am unable to identify any other trigger, my suspect is the booster I had.
Developed left eye ptosis and lateral deviation on 9/28/08.  This progressed somewhat until he was brought to medical attention the next day.  MRI of brain showed enhancing left third cranial nerve lesion.  Infectious and autoimmune workup negative except for CSF CMV PCR which was positive with negative serum serologies and PCR.  He was started on a short course of steriods and has been improving. 10/20/08-records received-Presented to ED 9/29/08- with C/O left eyelid drooping pupil dilation and eye deviated to left since day prior. Hit left eyebrow 2 weeks ago. Impression left 3rd nerve palsy.
Congestion, fluid in lungs, chest rattle --- day after Moderma Booster shot given
Information has been received from a nurse practitioner concerning her 25 year old daughter with Graves' disease (onset age 13) and no known allergies, who on unknown dates was vaccinated IM, with the first and second dose, 0.5 ml, of Gardasil (lot # not provided). Concomitant therapy included drospirenone (+) ethinyl estradiol (YASMIN). One month after the second vaccination was administered, her daughter required a visit to the emergency room (details not specified). She was found to have a blood pressure glucose of over 500 (unit not specified), and was diagnosed with Type I diabetes. Insulin was administered as treatment, and she was hospitalized for 1 week. At the time of this report, her daughter had not recovered. The nurse practitioner considered Type I Diabetes to be immediately life-threatening, disabling/incapacitating and also an other important medical event. Additional information has been requested.
Few minutes after the shot (10 min) was given patient passed out in Bathroom - Son said she does it all the time - We called Ambulance they checked her out & she went home
rash over entire body; fever 2 days 101; (rash lasted 4 days);
Side effects began the night after 2nd dose of SHINGRIX given. Patient reported severe sore arm (had difficulty falling asleep). The next day patient experienced severe confusion which resulted in patient forgetting to take her other medications. Patient reported slurred speech. She described that she "knew what she wanted to say, but couldn't say it". She couldn't verbalize her speech. Patient was driven to hospital/emergency room that evening. Doctor was able to determine that the patient did not have a stroke, however believed she had a reaction to the vaccine.
Bell's palsy; This is a spontaneous report from a non-contactable consumer (Patient). A 50-year-old female non-pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, lot number: ER8727, expiry date: unknown), via an unspecified route of administration in right arm on 24Mar2021 at 09:00, (at the age of 50-year-old) as a single dose, for COVID-19 immunisation. The patient medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  The patient concomitant medication was none. The patient previously took codeine and experienced allergies (known allergies_ codeine). The patient did not receive any other vaccine within 4 weeks prior to the vaccine. The patient experienced bell's palsy on 26Mar2021, at 07:00. The patient visited physician office and emergency room. The patient received steroids as treatment to the event. The outcome of the event was recovering  No follow up attempts are possible. No further information is expected.
A report has been received from a physician concerning a patient of unknown age and gender. On 17-JAN-2014 the patient received nasal FLUMIST but the vaccine was expired on 13-JAN-2014. The outcome of the event of expired FLUMIST was unknown. The report was considered to be non-serious by the reporter.
Urticarial rash from neck to ankles?confluence erythematous raised prurience lesions worsened  by scratching. Started 1 week after 2nd vaccine. booster. No contact agents or ingestants identified. No new meds.
Achy; Fever; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Achy), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) from 30-Mar-2021 to an unknown date for Antacid therapy, ASCORBIC ACID, BETACAROTENE, COPPER, NICOTINAMIDE, SELENIUM, TOCOPHEROL, XANTOFYL, ZINC (LUTEIN +) for Nutritional supplementation, VITAMIN D [VITAMIN D NOS] for Vitamin D deficiency.    On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced MYALGIA (Achy), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, MYALGIA (Achy), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, Body temperature: 102 (High) 102. In April 2021, Body temperature: 99.9 (High) 99.9.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-059800 (Patient Link).
slept all day; very sore arm; woke up trembling with chills; terrible chills; headache/bad headache; fatigue; diarrhea; This is a spontaneous report from a contactable consumer (patient). A 79-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on the left arm, on 12Jan2021 at a single dose for COVID-19 immunization. Medical history included major reaction to eating conch, and tested positive for COVID on 22Nov2020 There were no concomitant medications. Patient read that was not a good thing to do, to get the vaccine after only 2 months instead of 3 from diagnoses. When she had COVID she had major headache, chills, and diarrhea. After the vaccine she had had the same thing, terrible chills, bad headache and diarrhea on Jan2021. The side effects say that this was normal but she wants to know should she have waited the 90 days before getting the vaccine. Patient still had the headache and chills but she took an Imodium and the diarrhea was better. Patient had also fatigue in Jan2021,and slept all day yesterday (13Jan2021). She has had a very sore arm and at 2am she woke up trembling with chills on Jan2021. Outcome of the event chills and headache was not recovered, for diarrhea was recovering and for the remaining events was unknown. Patient had a major reaction to eating conch and wanted to make sure there was no shellfish involve in the vaccine.  Information on the batch/lot number has been requested.
Headache, Myalgia, NauseaVomiting, fatigue, chills Narrative:
Covid Booster & Flu shots were given at the same time in same L arm. 1. Reaction: within 2 weeks I noticed my urine looked like pain water and urination frequency was greatly increased. This has continued to present but in February I have had 4 nights of solid sleep. 2. Reaction" On 12/29/2023 I felt numbness creeping into the L side of my face from L side of my nose across my cheek. Both reactions seem to be waning. I am grateful especially for any solid nights sleep. Sleep deprivation seriously effects your ability to function. Also color has returned to my urine. I suspect the numbness in face may be Bell's Palsy but I experienced numbness but not paralysis.
lichen planus occurring in 1999 after starting series of anthrax immunizations. military stopped anthrax vaccinations and the problem resolved. has recurred again several months after restarting the anthrax vaccinations in 2006
have fever today; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (have fever today) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, the patient experienced PYREXIA (have fever today). At the time of the report, PYREXIA (have fever today) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not want to provide any additional information stated that he really was not feeling well and would just like the answer to his questions. No concomitant medications were reported. No information regarding corrective treatment was reported by the patient.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Significant follow-up received contains adverse event outcome changed from Unknown to recovered/resolved
Heart/chest pain, lasting approximately 6 hours until 200 mg of ibuprofen was administered orally.